Clinical Trial Update: A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer [NA]

View source ↗

Summary

This feasibility trial evaluated lithium as a neuroprotective agent in patients with small cell lung cancer undergoing prophylactic cranial irradiation, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Lithium (Lithium carbonate)

Snippet

Sponsor: Barwon Health | Conditions: Small Cell Lung Cancer | NA | Status: TERMINATED